334 related articles for article (PubMed ID: 37104556)
1. Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System.
Bálint L; Nelson-Maney NP; Tian Y; Serafin SD; Caron KM
Circ Res; 2023 Apr; 132(9):1185-1202. PubMed ID: 37104556
[TBL] [Abstract][Full Text] [Related]
2. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
3. Shared and separate functions of the RAMP-based adrenomedullin receptors.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
[TBL] [Abstract][Full Text] [Related]
4. Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.
Watkins HA; Chakravarthy M; Abhayawardana RS; Gingell JJ; Garelja M; Pardamwar M; McElhinney JM; Lathbridge A; Constantine A; Harris PW; Yuen TY; Brimble MA; Barwell J; Poyner DR; Woolley MJ; Conner AC; Pioszak AA; Reynolds CA; Hay DL
J Biol Chem; 2016 May; 291(22):11657-75. PubMed ID: 27013657
[TBL] [Abstract][Full Text] [Related]
5. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
6. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
7. The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.
Kuwasako K; Hay DL; Nagata S; Hikosaka T; Kitamura K; Kato J
Br J Pharmacol; 2012 May; 166(1):137-50. PubMed ID: 22142144
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP.
Holmes D; Campbell M; Harbinson M; Bell D
Curr Protein Pept Sci; 2013 Jun; 14(4):294-329. PubMed ID: 23745696
[TBL] [Abstract][Full Text] [Related]
10. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
Moad HE; Pioszak AA
Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
[TBL] [Abstract][Full Text] [Related]
11. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin: Continuing to explore cardioprotection.
Tsuruda T; Kato J; Kuwasako K; Kitamura K
Peptides; 2019 Jan; 111():47-54. PubMed ID: 29577955
[TBL] [Abstract][Full Text] [Related]
13. Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo.
Nouguerède E; Berenguer C; Garcia S; Bennani B; Delfino C; Nanni I; Dahan L; Gasmi M; Seitz JF; Martin PM; Ouafik L
Cancer Med; 2013 Apr; 2(2):196-207. PubMed ID: 23634287
[TBL] [Abstract][Full Text] [Related]
14. Is the activity of CGRP and Adrenomedullin regulated by RAMP (-2) and (-3) in Trypanosomatidae? An in-silico approach.
Febres A; Vanegas O; Giammarresi M; Gomes C; Díaz E; Ponte-Sucre A
Infect Genet Evol; 2018 Jul; 61():197-206. PubMed ID: 29626675
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cardiovascular development and homeostasis by the adrenomedullin-RAMP system.
Shindo T; Tanaka M; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Yamauchi A; Sakurai T
Peptides; 2019 Jan; 111():55-61. PubMed ID: 29689347
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin gene-related peptide-evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity.
Kunz TH; Scott M; Ittner LM; Fischer JA; Born W; Vogel J
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2155-60. PubMed ID: 17660394
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin: A potential therapeutic target for retinochoroidal disease.
Iesato Y; Yuda K; Chong KT; Tan X; Murata T; Shindo T; Yanagi Y
Prog Retin Eye Res; 2016 May; 52():112-29. PubMed ID: 26791747
[TBL] [Abstract][Full Text] [Related]
18. Ligand-induced internalization, recycling, and resensitization of adrenomedullin receptors depend not on CLR or RAMP alone but on the receptor complex as a whole.
Nag K; Sultana N; Kato A; Dranik A; Nakamura N; Kutsuzawa K; Hirose S; Akaike T
Gen Comp Endocrinol; 2015 Feb; 212():156-62. PubMed ID: 24815888
[TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
[TBL] [Abstract][Full Text] [Related]
20. Peptide ligand interaction with maltose-binding protein tagged to the calcitonin gene-related peptide receptor: The inhibitory role of receptor N-glycosylation.
Lee S
Peptides; 2022 Apr; 150():170735. PubMed ID: 35007660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
